24/7 Market News Snapshot 05 August, 2025 – Myriad Genetics Inc (NASDAQ:MYGN)

August 5, 2025

DENVER, Colo., 05 August, 2025 (www.247marketnews.com) – (NASDAQ:MYGN) are discussed in this article.
Myriad Genetics Inc. has been making waves in the stock market as shares surged over 30%, climbing from an opening price of $3.98 to currently trade at $5.18. This remarkable increase has been propelled by a heightened interest among investors, evidenced by a trading volume of 1.93 million shares. The strong upward movement reflects renewed confidence in the biotechnology sector, prompting analysts to watch for further gains and potential shifts in market sentiment.

The excitement surrounding Myriad Genetics coincides with the company’s recent financial disclosures for the second quarter of 2025. Myriad reported revenue of $213.1 million, which is a slight increase of 1% from the previous year. However, when accounting for specific challenges, adjusted revenue growth accelerated to 5% year-over-year, driven by a notable 9% rise in hereditary cancer testing revenue. The testing volume in the oncology sector also saw a commendable 10% increase, fueled by a 14% jump in MyRisk with RiskScore testing.

Despite facing a GAAP net loss of $330.5 million primarily due to non-cash impairment charges, Myriad improved its gross margin to 71.2%, marking a year-over-year increase of over 160 basis points. The company has also secured a $200 million credit facility to bolster its growth initiatives.

Sam Raha, President and CEO, emphasized the company’s commitment to enhancing its hereditary cancer testing offerings, while also expanding into prenatal health and mental health sectors. In a forward-looking move, Myriad has raised its full-year revenue guidance to between $818 million and $828 million, reflecting confidence in future performance. This disciplined approach to expense management positions Myriad Genetics for sustained profitability and growth across its diverse portfolio over the coming years.

Related news for (MYGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.